Uncategorized Archives - Life Sciences Times

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

August 11, 2025

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

August 7, 2025

THIS WEEK'S STORIES

Bionova Scientific Opens Texas Facility to Expand Plasmid DNA Production for Cell and Gene Therapy Market

August 12, 2025

FDA Grants De Novo Authorization to ArteraAI Prostate, First AI-Powered Digital Pathology Tool for Prostate Cancer Prognosis

August 13, 2025

Cardiosense Names Dr. John Martin as EVP and Chief Medical Officer Following FDA Clearance of CardioTag Device

August 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Uncategorized

LEO Pharma initiates head-to-head study to evaluate brodalumab vs. guselkumab in adult patients with moderate-to-severe psoriasis who have inadequate response to ustekinumab

Sigma Analytical Partners with Ecolab to Help Ensure Safe Production of Cannabis Products

Most Read

VitaTek Adds In-House Balloon Development Manufacturing to Streamline Medical Device Production

Apreo Health Treats First Patient in Pivotal BREATHE-3 Trial for Severe Emphysema

Archimedic Names Aaron Pavkov Chief Innovation Officer to Drive Medical Device Development

Sarepta Therapeutics Advances siRNA Program for DM1, Sells Arrowhead Stake to Fund $100M Milestone Payment

EDITOR PICKS

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

THIS WEEK'S STORIES

Bionova Scientific Opens Texas Facility to Expand Plasmid DNA Production for Cell and Gene Therapy Market

FDA Grants De Novo Authorization to ArteraAI Prostate, First AI-Powered Digital Pathology Tool for Prostate Cancer Prognosis

Cardiosense Names Dr. John Martin as EVP and Chief Medical Officer Following FDA Clearance of CardioTag Device

POPULAR CATEGORY

ABOUT US

FOLLOW US

Uncategorized

No posts to display

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

FOLLOW US